Diversified Healthcare Trust DHC.OQ DHC.O is expected to show a rise in quarterly revenue when it reports results on February 26 for the period ending December 31 2023
The Newton Massachusetts-based company is expected to report a 7.2% increase in revenue to $360.993 million from $336.89 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data. (Sales/Revenue Majority Basis is onTotal Revenue)
LSEG's mean analyst estimate for Diversified Healthcare Trust is for a loss of 25 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Diversified Healthcare Trust is $4.50, above its last closing price of $2.96.
This summary was machine generated February 24 at 00:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)